Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 6101 - 6125 of 6514 in total
Daglutril is an orally active, mixed neutral endopeptidase/endothelin converting enzyme inhibitor under development for the treatment of essential hypertension and congestive heart failure.
Investigational
Investigational
Hemoglobin in which the alpha-subunit are cross-linked intramolecularly.
Experimental
Investigational
Investigational
Rozrolimupab is a recombinant polyclonal antibody consisting of 25 different anti-Rhesus D (RhD) antibodies to replace existing anti-RhD hyperimmune immunoglobulins for the treatment of Idiopathic Thrombocytopenic Purpura (ITP) and the prevention of Hemolytic Disease of Newborns (HDN).
Investigational
Vet approved
Investigational
BS-001 is a recombinant oncolytic herpes simplex virus type II (OH2) therapeutic injection (Vero cell) for human use (rHSV2hGM-CSF).
Investigational
AB-201 is a CAR-NK cell therapy targeted against HER2. It is under investigation for the treatment of HER2-positive cancers, including breast and gastric carcinomas.
Investigational
Ozagrel has been used in trials studying the treatment of Dry Eye Syndromes.
Investigational
Displaying drugs 6101 - 6125 of 6514 in total